SG Americas Securities
PYXS icon

SG Americas Securities’s Pyxis Oncology PYXS Stock Holding History

SG Americas Securities’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-15,800
Closed -$58K – 3524
2024
Q3 		$58K Buy
+15,800
New +$55.3K ﹤0.01% 3216
2024
Q2 		– Sell
-13,809
Closed -$59K – 3226
2024
Q1 		$59K Buy
+13,809
New +$58.1K ﹤0.01% 2715
2023
Q4 		– Sell
-19,996
Closed -$40K – 3379
2023
Q3 		$40K Sell
19,996
-501
-2% -$1.16K ﹤0.01% 2978
2023
Q2 		$52K Buy
+20,497
New +$65K ﹤0.01% 2135

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

SG Americas Securities's PYXS Position: Q4 2024 in Review

SG Americas Securities sold out of Pyxis Oncology (PYXS) in Q4 2024, closing a stake of 15,800 shares — an estimated $58K sold.

SG Americas Securities first reported a position in PYXS in Q2 2023 and held it in 4 quarters. The position peaked at $59K in Q1 2024. 99 funds tracked by Wall St. Rank hold PYXS as of Q4 2024.

  • SG Americas Securities reported no remaining Pyxis Oncology position as of Q4 2024 after selling out during the quarter.
  • SG Americas Securities sold 15,800 Pyxis Oncology shares in Q4 2024, an estimated $58K.
  • SG Americas Securities first reported a position in Pyxis Oncology in Q2 2023 and held it in 4 quarters.
  • SG Americas Securities's Pyxis Oncology position peaked at $59K in Q1 2024.
  • 99 funds tracked by Wall St. Rank held Pyxis Oncology as of Q4 2024.

Based on SG Americas Securities's 13F filing for Q4 2024, filed 17 Jan 2025.